BNP Paribas Financial Markets’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-572,196
Closed -$56.8M 4607
2019
Q3
$56.8M Sell
572,196
-490,944
-46% -$46.6M 0.1% 204
2019
Q2
$98.3M Sell
1,063,140
-96,079
-8% -$9.12M 0.2% 116
2019
Q1
$109M Sell
1,159,219
-1,695,691
-59% -$148M 0.24% 83
2018
Q4
$183M Buy
2,854,910
+2,043,902
+252% +$151M 0.43% 34
2018
Q3
$72.6M Sell
811,008
-421,348
-34% -$37.2M 0.11% 191
2018
Q2
$97.9M Buy
1,232,356
+367,015
+42% +$30.5M 0.16% 125
2018
Q1
$77.2M Buy
865,341
+322,010
+59% +$30.9M 0.14% 132
2017
Q4
$56.7M Sell
543,331
-784,326
-59% -$88.5M 0.1% 193
2017
Q3
$194M Sell
1,327,657
-44,380
-3% -$6.05M 0.47% 38
2017
Q2
$178M Buy
1,372,037
+140,717
+11% +$17.2M 0.54% 29
2017
Q1
$153M Buy
1,231,320
+923,919
+301% +$111M 0.4% 50
2016
Q4
$35.6M Sell
307,401
-180,671
-37% -$20.1M 0.17% 108
2016
Q3
$51M Buy
488,072
+192,259
+65% +$20.8M 0.21% 89
2016
Q2
$29.2M Sell
295,813
-102,682
-26% -$10.6M 0.13% 111
2016
Q1
$39.9M Buy
398,495
+13,309
+3% +$1.37M 0.17% 101
2015
Q4
$46.1M Buy
385,186
+207,178
+116% +$24M 0.11% 151
2015
Q3
$19.3M Sell
178,008
-244,936
-58% -$30.4M 0.05% 260
2015
Q2
$49M Sell
422,944
-305,053
-42% -$34.9M 0.14% 96
2015
Q1
$83.9M Sell
727,997
-75,365
-9% -$9.01M 0.23% 64
2014
Q4
$89.9M Sell
803,362
-26,959
-3% -$2.84M 0.32% 57
2014
Q3
$78.7M Buy
830,321
+328,750
+66% +$29.7M 0.07% 149
2014
Q2
$43.1M Sell
501,571
-389,129
-44% -$29.6M 0.04% 172
2014
Q1
$65.5M Sell
890,700
-671,610
-43% -$53.2M 0.05% 146
2013
Q4
$132M Buy
1,562,310
+36,712
+2% +$2.9M 0.1% 116
2013
Q3
$118M Buy
1,525,598
+885,632
+138% +$62.1M 0.09% 133
2013
Q2
$37.4M Buy
+639,966
New +$38.5M 0.03% 182

Other funds holding CELG

BNP Paribas Financial Markets's CELG Position: Q4 2019 in Review

BNP Paribas Financial Markets sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 572,196 shares — an estimated $56.8M sold.

BNP Paribas Financial Markets first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $194M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • BNP Paribas Financial Markets reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 572,196 Celgene Corp shares in Q4 2019, an estimated $56.8M.
  • BNP Paribas Financial Markets first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • BNP Paribas Financial Markets's Celgene Corp position peaked at $194M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.